Skip Navigation

JNCI Journal of the National Cancer Institute 2004 96(3):240-241; doi:10.1093/jnci/djh046
© 2004 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Leitzmann, M. F.
Right arrow Articles by Giovannucci, E.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Leitzmann, M. F.
Right arrow Articles by Giovannucci, E.
Related Collections
Right arrowRelated Correspondence
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2004 Oxford University Press

CORRESPONDENCE

RESPONSE: Re: Zinc Supplement Use and Risk of Prostate Cancer

Michael F. Leitzmann, Edward Giovannucci

Affiliations of authors: Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD (MFL); Departments of Nutrition and Epidemiology, Harvard School of Public Health, Boston, MA (EG).

Correspondence to: Michael F. Leitzmann, MD, Division of Cancer Epidemiology and Genetics, National Cancer Institute, 6120 Executive Blvd., EPS-MSC 7232, Bethesda, MD 20892 (e-mail: leitzmann@mail.nih.gov)

The first 10% of the full text of this article appears below.

We respond briefly to the points raised by Costello et al. concerning our paper on zinc supplement use and the risk of prostate cancer (1). First, Costello et al. suggest that we should have provided P values for the pair-wise statistical comparisons of each zinc-user group with the nonuser group and used the Bonferroni correction for multiple comparisons. However, . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related Correspondence

Re: Zinc Supplement Use and Risk of Prostate Cancer
Leslie C. Costello, Renty B. Franklin, Pei Feng, and Ming Tan
J Natl Cancer Inst 2004 96: 239-240. [Extract] [Full Text] [PDF]